We partner with biotech, pharmaceutical and contract research companies of every size and spend, from start ups to global leaders.
Our client portfolio is deep, international, diverse and working to support the forefront of medical science through to drug delivery.
Many clinical research protocols require screening for drugs-of-abuse in a clinical trial. Rapid immunoassay/POCT screening is a cost-effective streamlined alternative to laboratory screening to determine if an individual meets the necessary study criteria.
Drug screening can be performed directly at the investigative site and provide results in as little as 5 minutes. Panels can be customized for individual study protocols with up to 16 analytes and can be batched to ensure lot consistency. Identifying early if an individual is considered not appropriate for participation in research studies can save considerable time and cost.
We will work as a flexible, attentive extension of your team to provide products and support as you navigate complex study needs to move your study forward on time and on budget.